Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
Chest
|
January 10, 2021
The Promise (and Pitfalls) of Administrative Data for Idiopathic Pulmonary Fibrosis
Jolene H Fisher
Clinics in Chest Medicine
|
May 24, 2021
Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center
Jolene H Fisher, Vincent Cottin
Annals of the American Thoracic Society
|
April 28, 2026
Interstitial Lung Abnormalities: Age as Driver, Fibrosis as Destiny?
Tyler Pitre, Jolene H Fisher
Chest
|
November 8, 2020
Moving From Multidisciplinary Phenotyping to Biological Classification of Fibrotic Interstitial Lung Disease
Jolene H Fisher, Christopher J Ryerson
Annals of the American Thoracic Society
|
April 29, 2022
The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung Disease
Alyson W Wong, Jolene H Fisher
Current Rheumatology Reports
|
July 6, 2022
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes
Kelly Sun, Jolene H Fisher, Christian Pagnoux
Annals of the American Thoracic Society
|
February 10, 2021
An Updated Assessment of Online Information on Idiopathic Pulmonary Fibrosis
Japnam S Grewal, Jolene H Fisher, Christopher J Ryerson
ATS Scholar
|
August 1, 2025
Multidisciplinary Videoconferencing for Physician Education and Remote Management of Interstitial Lung Disease
Sarah Pankovitch, Shane Shapera, Lee Fidler, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 22, 2022
Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse
Kerri A Johannson, Martin Kolb, Jolene H Fisher, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
July 28, 2021
Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease
Lee M Fidler, Sonja Kandel, Jolene H Fisher, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
Chest
|
January 10, 2021
The Promise (and Pitfalls) of Administrative Data for Idiopathic Pulmonary Fibrosis
Jolene H Fisher
Clinics in Chest Medicine
|
May 24, 2021
Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center
Jolene H Fisher, Vincent Cottin
Annals of the American Thoracic Society
|
April 28, 2026
Interstitial Lung Abnormalities: Age as Driver, Fibrosis as Destiny?
Tyler Pitre, Jolene H Fisher
Chest
|
November 8, 2020
Moving From Multidisciplinary Phenotyping to Biological Classification of Fibrotic Interstitial Lung Disease
Jolene H Fisher, Christopher J Ryerson
Annals of the American Thoracic Society
|
April 29, 2022
The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung Disease
Alyson W Wong, Jolene H Fisher
Current Rheumatology Reports
|
July 6, 2022
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes
Kelly Sun, Jolene H Fisher, Christian Pagnoux
Annals of the American Thoracic Society
|
February 10, 2021
An Updated Assessment of Online Information on Idiopathic Pulmonary Fibrosis
Japnam S Grewal, Jolene H Fisher, Christopher J Ryerson
ATS Scholar
|
August 1, 2025
Multidisciplinary Videoconferencing for Physician Education and Remote Management of Interstitial Lung Disease
Sarah Pankovitch, Shane Shapera, Lee Fidler, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 22, 2022
Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse
Kerri A Johannson, Martin Kolb, Jolene H Fisher, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
July 28, 2021
Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease
Lee M Fidler, Sonja Kandel, Jolene H Fisher, et al.
Page
of 9